Management of acute allergic reactions to food
There are no recommended medications for the prevention of immunoglobulin E (IgE)-mediated, non-IgE-mediated or mixed food-induced allergic reactions. [1, 2] Medication may, however, be used to treat both severe and non-severe allergic reactions. While treating mild-to-moderate food allergic reactions, the patient should be closely monitored for any signs or symptoms of an anaphylactic reaction.
Anaphylaxis may be fatal if not recognised and managed appropriately with rapid treatment. The drug of choice for the treatment of an anaphylactic reaction is intramuscular adrenaline, with other drugs given as adjuctive therapy. [3, 4] In cases of suboptimal response to the initial dose of adrenaline, or with progression of symptoms, a repeat dose should be given. [5] Basic cardiopulmonary resuscitation should be initiated and maintained to support the airway, oxygenation and circulation. The following steps should be instituted in the initial management of anaphylaxis:
• eliminate additional exposure to the allergen • administer intramuscular injection(s) of adrenaline • call for help • place the patient in a recumbent position, with lower limbs elevated, and do not allow the patient to stand up quickly • give supplemental oxygen • administer intravenous fluid in cases of hypotension or incomplete response to intramuscular adrenaline • administer adjunctive therapy (antihistamines and corticosteroids) • admit the patient for close observation for biphasic reactions
• instigate or review risk-reduction strategies after an anaphylactic episode.
Adrenaline is the drug of choice as first-line management of anaphylaxis. There are no absolute contraindications to treatment with adrenaline. [4, 6] It should be administered intramuscularly (not subcutaneously) at a dose of 0.01 mg.kg -1 (0.01 mL/kg of 'neat' adrenaline; maximum 0.5 mL) in the mid-anterolateral thigh to achieve peak tissue and plasma concentrations rapidly. [1] Adrenaline auto-injectors (e.g. EpiPen) are more convenient options than ampoules and syringes, which may be difficult to use quickly or accurately -especially by parents or patients in emergency situations. EpiPen injectors are available containing fixed doses of 0.15 mg and 0.30 mg adrenaline. [7] H 1 antihistamines may be used to decrease skin symptoms (itch, flush and urticaria) and nasal symptoms (rhinorrhoea and congestion) and are therefore beneficial in children and adults with non-lifethreatening manifestations of food allergy. H 1 antihistamines cannot prevent or treat life-threatening manifestations of anaphylaxis. [8] They are, however, used as adjunctive therapy to adrenaline. Less-sedating oral second-generation antihistamines are preferred to sedating firstgeneration antihistamines. [9] Intravenous antihistamines should be used if oral medication is not tolerated or contraindicated.
Corticosteroids are often used in anaphylaxis, but they have a delayed mechanism of action and are not useful during an acute episode. However, their anti-inflammatory properties may make them suitable as adjunctive therapy to reduce the risk of biphasic reactions. [1, 5] An anaphylactic reaction may be fatal if not recognised and managed appropriately with rapid treatment. Key steps in the management of anaphylaxis include eliminating additional exposure to the allergen, basic life-support measures and prompt intramuscular administration of adrenaline 0.01 mg/kg (maximum 0.5 mL). Adjunctive measures include nebulised bronchodilators for lower-airway obstruction, nebulised adrenaline for stridor, antihistamines and corticosteroids. Patients with an anaphylactic reaction should be admitted to a medical facility so that possible biphasic reactions may be observed and risk-reduction strategies initiated or reviewed after recovery from the acute episode.
Factors associated with increased risk of severe reactions include co-existing asthma (and poor asthma control), previous severe reactions, delayed administration of adrenaline, adolescents and young adults, reaction to trace amounts of foods, use of non-selective β-blockers and patients who live far from medical care.
Risk-reduction measures include providing education with regard to food allergy and a written emergency treatment plan on allergen avoidance, early symptom recognition and appropriate emergency treatment. Risk assessment allows stratification with provision of injectable adrenaline (preferably via an auto-injector) if necessary. Patients with ambulatory adrenaline should be provided with written instructions regarding the indications for and method of administration of this drug and trained in its administration. Patients and their caregivers should be instructed about how to avoid foods to which the former are allergic and provided with alternatives. Permission must be given to inform all relevant caregivers of the diagnosis of food allergy. The patient must always wear a MedicAlert necklace or bracelet and be encouraged to join an appropriate patient support organisation.
The initial pharmacological management of anaphylaxis is given in Table 1 .
Co-factors for reactions
A number of co-factors may augment or amplify the severity of allergic reactions. [12] Given their importance in eliciting anaphylaxis, these co-factors need to be included in diagnostic measures and management. They include the following:
• Physical exercise. Food-dependent exerciseinduced anaphylaxis may occur if exercise and consumption of a certain food occur within 4 hours of each other. The implicated food is usually well tolerated when the patient does not exercise.
• Medication includes non-steroidal antiinflammatory drugs, such as aspirin, ibuprofen and opiates. [13] • Alcohol. [14] • Fever and infectious diseases. [15] • High-pollen season. In oral allergy syndrome, symptoms may be heightened during pollen season.
Although an anaphylactic reaction seems to be triggered by a sole allergen in most cases, exposure to a single allergen is sometimes not enough to trigger an episode. Concomitant exposure to a combination of allergens, infections, physical exercise, psychological stress, alcohol and/or concomitant medication are necessary to provoke a reaction, i.e. summation anaphylaxis.
Risk factors associated with the severity of allergic reactions to foods
The severity of allergic reactions to food allergens is multifactorial and variable. The severity of any reaction cannot be accurately predicted by the degree of the severity of any previous reaction, or by the size of the wheal of a skin-prick test or level of specific IgE. Factors associated with increased risk, as shown in epidemiological studies, [16] [17] [18] [19] [20] [21] [22] [23] [24] include co-existing asthma (and poor asthma control), previous severe reactions, delayed administration of adrenaline, adolescents and young adults, reaction to trace amounts of foods, use of non-selective β-blockers and patients in remote areas far from medical care. Self-injectable adrenaline is under-used, even when available, and incorrect administration may also be an important factor, particularly when administered by needle and syringe rather than by an auto-injector. [4] Risk reduction [25] The following factors should be considered in reducing the risk of an allergic reaction:
• Education with regard to food allergy and provision of a written emergency treatment plan on allergen avoidance, early symptom recognition and appropriate emergency treatment. [1] First-line treatment Adrenaline IM, 1:1 000 solution Adrenaline dose might need to be repeated every 5 -15 minutes Via needle and syringe: adrenaline (undiluted 1:1 000 concentration) IM, 0.01 mg/kg per dose (equivalent to 0.01 mL/kg); maximum 0.5 mg/dose in the anterolateral thigh
Auto-injectors Weight 8 -25 kg: 0.15 mg IM in the anterolateral thigh [10, 11] Weight >25 kg: 0.3 mg IM in the anterolateral thigh [10, 11] Adjunctive treatment Bronchodilators (β 2 -agonist): salbutamol or fenoterol by metered-dose inhaler or nebulisation for lower-airway obstruction
Inhaled nebulised adrenaline for upper-airway obstruction
Corticosteroids IM = intramuscularly. Table 2 . Indications for the prescription of self-injectable adrenaline devices in the community [14] 
Absolute indications
Previous anaphylactic reaction to a food, insect sting, latex or unavoidable aeroallergen Co-existent unstable or moderate-to-severe persistent asthma and food allergy
Idiopathic anaphylaxis
Food-dependent exercise-induced anaphylaxis
Relative indications
Mild-to-moderate peanut/and or tree nut allergy in patients ≥5 years of age Food allergy in a teenager or young adult
Far from a medical facility
Reactions to small amounts of food, such as air-borne food allergens or contact via skin only Indications for the prescription of self-injectable adrenaline devices in the community are given in Table 2 .
Food allergy education
Strict avoidance of allergens
• Strict avoidance of allergens is the cornerstone of allergy management, although it is not curative and leaves patients at risk for accidental exposure.
• Only foods to which the patient is allergic should be avoided.
• Patients should receive education about label reading and medical terminology related to the identification of allergens.
• Patients should receive instruction with regard to cross-reactive allergens.
• It is advisable to involve a dietician in formulating a nutritionally adequate, allergen-free diet, especially in cases of multiple food allergy.
• Information on how to minimise cross-contact of foods with an allergen during meal preparation and serving can help to prevent accidental ingestion and reactions.
• Education on high-risk accidental ingestion, especially of foods prepared away from home (e.g. eating out, visiting friends' homes, or attending parties).
Early recognition of allergic reactions and anaphylaxis
• A written emergency plan should be given to the patient; their caregivers should be notified about the food allergy and given a copy of the plan. Plans are available at http://www.allergysa.org.
• The emergency plan should contain an image clearly differentiating between mild reactions and reactions requiring the use of adrenaline.
• Antihistamines are used for the management of non-severe allergic reactions.
• When only antihistamines are used for the treatment of acute allergic reactions, patients should be monitored should they develop more severe symptoms.
• As soon as a patient has an anaphylactic reaction, they should be placed in the supine position with lower extremities elevated; they should not stand up and move as this has been reported to increase the risk of severe anaphylaxis or sudden death. • Adrenaline should be administered for all reactions that exceed the threshold in the action plan. If the patient or caregiver is considering using adrenaline, it is usually safer to give it immediately rather than to wait until definitive signs or symptoms appear. • A MedicAlert bracelet or necklace should be provided to all patients at risk of anaphylaxis.
Provision of an emergency kit, including self-injectable adrenaline and intravenous antihistamine
• Adrenaline is the mainstay of treating anaphylaxis.
• Giving adrenaline via an auto-injector is preferable to administering it via a needle and syringe.
Provision of instructions on when to go to a medical facility
• Patients should be informed when to go to a medical facility if they are experiencing symptoms of an anaphylactic reaction.
• For patients with a history of severe allergic reactions, adrenaline should be administered at the onset of mild symptoms; then they should proceed to an emergency facility.
• Patients experiencing an anaphylactic episode should be observed in a medical facility for at least 12 -24 hours because of the risk of biphasic reactions.
Educate patients about long-term ongoing management
• Long-term management must include at least an annual medical review to assess accidental ingestion, reactions, or both, nutritional adequacy of their diet, approaches to allergen avoidance and need for retesting for resolution of food allergy.
• At each visit, risk assessment for asthma, re-education about early recognition and emergency treatment plans should be reviewed.
